These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Cardiogenic shock in acute myocardial infarction--what we know in 2005]. Vojácek J, Bis J. Cas Lek Cesk; 2005; 144 Suppl 3():30-2. PubMed ID: 16335260 [Abstract] [Full Text] [Related]
32. [Causes of death in myocardial infarct complicated by cardiogenic shock during the use of intra-aortic balloon counterpulsation in their treatment]. Barvyn' VG, Gorodkova EB. Kardiologiia; 1982 Oct; 22(10):34-7. PubMed ID: 7176315 [Abstract] [Full Text] [Related]
33. Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction. Christoph A, Prondzinsky R, Russ M, Janusch M, Schlitt A, Lemm H, Reith S, Werdan K, Buerke M. Acute Card Care; 2008 Oct; 10(1):49-57. PubMed ID: 17924229 [Abstract] [Full Text] [Related]
34. Early 'in-lab' use of levosimendan in patients with cardiogenic shock unsuitable for intra-aortic balloon pump counterpulsation. Summaria F, Mustilli M, Sette A, Lanzillo C, Romagnoli E. Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):28-31. PubMed ID: 24492986 [Abstract] [Full Text] [Related]
36. [Intra-aortic balloon counterpulsation in the treatment of severe cardiac insufficiency in acute myocardial infarct]. Pini R, Vannucci A, Marchionni N, Greppi B, Di Bari M, Conti A. G Ital Cardiol; 1981 Feb; 11(11):1700-7. PubMed ID: 7343373 [No Abstract] [Full Text] [Related]